BRCA2 and ovarian carcinoma: As our study was limited by the inability to perform a comprehensive screen of both BRCA1 and BRCA2 due to cost limitations and the use of banked samples rather than a series, the overall frequency of mutation carriers in ovarian cancer cases not selected for cancer family history remains unknown.